Editorial
Pleomorphic Basal Cell Carcinoma
Abstract
Basal cell carcinoma (BCC) is arguably the most common cancer in the United States. In 2006, there will be approximately one million new BCCs diagnosed meaning that almost 50% of new cancers will be a BCC. Because of its ubiquitous nature, a general knowledge of this tumor is important for most clinicians.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.